Research Reports

Though virtually all aspects of clinical laboratory testing are subject to governmental oversight, Uncle Sam's regulatory reach has been vastly expanded by the new Medicare reform law (the Medicare Modernization Act of 2003).

So, to successfully conduct business in today's complex, often confusing regulatory environment, it's vital that laboratory executives,coding and billing professionals understand what is required and what is not.

Save time and worry by having at your fingertips this unrivalled, concise report that answers - in plain English - the basic questions a clinical laboratory confronts when doing business with the New Medicare, including:

• Major changes in laboratory and pathology requirements under the Medicare reform law (the Medicare Modernization Act of 2003)
  
• In-depth explanation of how the government is moving to implement these changes
  
• Key policy directives and clarifications from the Centers for Medicare & Medicaid Services, the Food & Drug
  Administration, and the HHS Office of Inspector General
  
• Common Medicare billing issues and special situations for ESRD patients and skilled nursing facility residents
  
• Analysis of the impact on CLIA and compliance program requirements
  
• Special rules for physician pathology services, including surgical pathology, cytopathology, purchased diagnostic testing, and benefits reassignment
  

Preview the report's Table of Contents and Preface.